Location History:
- Jiangsu, CN (2015)
- Changzhou, CN (2023)
Company Filing History:
2 out of 2 
1 out of 1 
1 out of 1 Years Active: 2015-2023
Title: Yongrui Tu: Innovator in Pharmaceutical Solutions
Introduction
Yongrui Tu is a notable inventor based in Jiangsu, China. He has made significant contributions to the pharmaceutical industry, particularly in the development of innovative drug formulations. With a total of 2 patents, his work focuses on improving medication stability and accessibility for patients.
Latest Patents
One of his latest patents is for a pramipexole hydrochloride oral liquid. This invention provides a method for enhancing the stability of pramipexole or its salt preparation. The oral liquid demonstrates excellent stability and oral absorption effects. It is prepared through a simple process and shows bioequivalence with the tablet form of pramipexole hydrochloride. This innovation allows for multi-dose administration, improving patient compliance and medication accessibility.
Another significant patent by Yongrui Tu is a method for preparing ulipristal acetate and its key intermediates. This method introduces new intermediates that facilitate the preparation of ulipristal acetate. The process is efficient, with a high yield of 75% and a purity exceeding 98%. The reagents used are cost-effective, making this method both practical and economical for pharmaceutical applications.
Career Highlights
Yongrui Tu has worked with prominent companies in the pharmaceutical sector, including Changzhou No. 4 Pharmaceutical Factory Co., Ltd and Beijing Do-pharma Tech Co. Ltd. His experience in these organizations has contributed to his expertise in drug formulation and development.
Collaborations
Throughout his career, Yongrui Tu has collaborated with notable professionals in the field, including Xinhua Fan and Yanyuan Zhang. These collaborations have further enriched his research and development efforts.
Conclusion
Yongrui Tu's innovative contributions to the pharmaceutical industry highlight his commitment to improving drug formulations and patient care. His patents reflect a deep understanding of pharmaceutical science and a dedication to enhancing medication accessibility.